Cargando…
A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval
PURPOSE: To construct a proper model to screen for diabetic retinopathy (DR) with the RETeval. METHOD: This was a cross-sectional study. Two hundred thirty-two diabetic patients and seventy controls were recruited. The DR risk assessment protocol was performed to obtain subjects’ DR risk score using...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074966/ https://www.ncbi.nlm.nih.gov/pubmed/33912134 http://dx.doi.org/10.3389/fendo.2021.632457 |
_version_ | 1783684458560356352 |
---|---|
author | Deng, Xiaowen Li, Zijing Zeng, Peng Wang, Jing Liang, Jiaqi Lan, Yuqing |
author_facet | Deng, Xiaowen Li, Zijing Zeng, Peng Wang, Jing Liang, Jiaqi Lan, Yuqing |
author_sort | Deng, Xiaowen |
collection | PubMed |
description | PURPOSE: To construct a proper model to screen for diabetic retinopathy (DR) with the RETeval. METHOD: This was a cross-sectional study. Two hundred thirty-two diabetic patients and seventy controls were recruited. The DR risk assessment protocol was performed to obtain subjects’ DR risk score using the RETeval. Afterwards, the receiver operating characteristic (ROC) curve was used to determine the best cutoff for diagnosing DR. Random forest and decision tree models were constructed. RESULTS: With increasing DR severity, the DR score gradually increased. When the DR score was used to diagnose DR, the ROC curve had an area under the curve of 0.881 (95% confidence interval: 0.836-0.927, P < 0.001), with a best cutoff value of 22.95, a sensitivity of 74.3% (95 CI: 66.0%~82.6%), and a specificity of 90.6% (95 CI: 83.7% ~94.8%). The top four risk factors selected by the random forest were used to construct the decision tree for diagnosing DR, which had a sensitivity of 93.3% (95% CI: 86.3%~97.0%) and a specificity of 80.3% (95% CI: 72.1% ~86.6%). CONCLUSIONS: The DR risk assessment protocol combined with the decision tree model was innovatively used to evaluate the risk of DR, improving the sensitivity of diagnosis, which makes this method more suitable than the current protocol for DR screening. |
format | Online Article Text |
id | pubmed-8074966 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80749662021-04-27 A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval Deng, Xiaowen Li, Zijing Zeng, Peng Wang, Jing Liang, Jiaqi Lan, Yuqing Front Endocrinol (Lausanne) Endocrinology PURPOSE: To construct a proper model to screen for diabetic retinopathy (DR) with the RETeval. METHOD: This was a cross-sectional study. Two hundred thirty-two diabetic patients and seventy controls were recruited. The DR risk assessment protocol was performed to obtain subjects’ DR risk score using the RETeval. Afterwards, the receiver operating characteristic (ROC) curve was used to determine the best cutoff for diagnosing DR. Random forest and decision tree models were constructed. RESULTS: With increasing DR severity, the DR score gradually increased. When the DR score was used to diagnose DR, the ROC curve had an area under the curve of 0.881 (95% confidence interval: 0.836-0.927, P < 0.001), with a best cutoff value of 22.95, a sensitivity of 74.3% (95 CI: 66.0%~82.6%), and a specificity of 90.6% (95 CI: 83.7% ~94.8%). The top four risk factors selected by the random forest were used to construct the decision tree for diagnosing DR, which had a sensitivity of 93.3% (95% CI: 86.3%~97.0%) and a specificity of 80.3% (95% CI: 72.1% ~86.6%). CONCLUSIONS: The DR risk assessment protocol combined with the decision tree model was innovatively used to evaluate the risk of DR, improving the sensitivity of diagnosis, which makes this method more suitable than the current protocol for DR screening. Frontiers Media S.A. 2021-04-12 /pmc/articles/PMC8074966/ /pubmed/33912134 http://dx.doi.org/10.3389/fendo.2021.632457 Text en Copyright © 2021 Deng, Li, Zeng, Wang, Liang and Lan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Deng, Xiaowen Li, Zijing Zeng, Peng Wang, Jing Liang, Jiaqi Lan, Yuqing A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval |
title | A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval |
title_full | A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval |
title_fullStr | A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval |
title_full_unstemmed | A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval |
title_short | A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval |
title_sort | diagnostic model for screening diabetic retinopathy using the hand-held electroretinogram device reteval |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074966/ https://www.ncbi.nlm.nih.gov/pubmed/33912134 http://dx.doi.org/10.3389/fendo.2021.632457 |
work_keys_str_mv | AT dengxiaowen adiagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval AT lizijing adiagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval AT zengpeng adiagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval AT wangjing adiagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval AT liangjiaqi adiagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval AT lanyuqing adiagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval AT dengxiaowen diagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval AT lizijing diagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval AT zengpeng diagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval AT wangjing diagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval AT liangjiaqi diagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval AT lanyuqing diagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval |